What Biogen’s Alzheimer’s Drug Results Means for the Company’s Stock

By |2023-12-07T21:11:17+00:00September 28th, 2022|Categories: Feature: Stock Market Investing, Featured: News, Stocks in the News|Tags: , , , , |

Yesterday, we discussed how Crispr stock enjoyed a short-lived jump ahead of seeking FDA approval for their gene therapy drug. But today, we’re here to talk about a drug company that has experienced a much larger spike as a result of positive news: Biogen. Biogen is engaged in discovering, developing, and delivering therapies for [...]